Evidence map›Paper›PMID 41756748›Full record

ArticleInternational journal of particle therapy2026

Comparing Organs at Risk Sparing Between Intensity-Modulated Radiotherapy and Pencil-Beam Scanning Plans Based on Disease Location for Hodgkin and Non-Hodgkin Lymphoma.

Keaton Reiners, Emma Viviers, Nataly Getman, Kevin Kirby, Perry B Johnson, Nancy P Mendenhall, Yawei Zhang, Raymond B Mailhot Vega

Abstract read
In one paragraph

Article in International journal of particle therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Keaton ReinersDepartment of Radiation Oncology, University of Florida College of Medicine, Jacksonville, FL, USA.
Emma ViviersDepartment of Radiation Oncology, Mayo Clinic Jacksonville, Jacksonville, FL, USA.
Nataly GetmanUniversity of Florida Health Therapy Institute, Jacksonville, FL, USA.
Kevin KirbyUniversity of Florida Health Therapy Institute, Jacksonville, FL, USA.
Perry B JohnsonDepartment of Radiation Oncology, University of Florida College of Medicine, Jacksonville, FL, USA.
Nancy P MendenhallDepartment of Radiation Oncology, University of Florida College of Medicine, Jacksonville, FL, USA.
Yawei ZhangDepartment of Radiation Oncology, University of Florida College of Medicine, Jacksonville, FL, USA.
Raymond B Mailhot VegaDepartment of Radiation Oncology, University of Florida College of Medicine, Jacksonville, FL, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Radiotherapy (RT) is often used as a combined modality therapy for patients with Hodgkin (HL) and aggressive Non-Hodgkin Lymphoma (aNHL). RT options include photon intensity-modulated radiotherapy (IMRT) or proton therapy (PT). As PT is a limited and costly resource, it is important to identify cases in which PT may best benefit in order to offer providers and patients the best possible information for decision-making. Accordingly, the purpose of this study was to assess the difference in OAR sparing between photon IMRT and pencil-beam scanning (PBS) based on disease location using the Ann Arbor (AA) staging system. Materials and Methods: A cohort was established including all patients with HL or aNHL ( Results: PBS reduced the mean heart dose with the largest AS (6.4 Gy) for patients with UML mediastinal involvement. Greatest AS and RS for lung V20 was seen for patients with bilateral axillary involvement (20.9% AS, 53.5% RS), and for mean breast dose greatest sparing was seen for those with bilateral hilar disease (5.1 Gy AS, 58.6% RS). Conclusion: The use of PBS resulted in a substantial decrease in the mean dose to OARs, the magnitude of which depended on the location in which disease was present. This work advances that the anatomic location of involvement is an important influence on the relative benefit of PT.

Indexed as

Hodgkin lymphomaLymphomaNon-Hodgkin lymphomaProton therapy

Identifiers

PMID41756748
PMCPMC12933442

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.